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Neutron production is of principal concern when designing proton therapy vault shielding.
Conventionally, neutron calculations are based on analytical methods, which do not accurately
consider beam shaping components and nozzle shielding. The goal of this study was to calculate,
using Monte Carlo modeling, the neutron spectral fluence and neutron dose equivalent generated
by a realistic proton therapy nozzle and evaluate how these data could be used in shielding
calculations. We modeled a contemporary passive scattering proton therapy nozzle in detail with
the MCNPX simulation code. The neutron spectral fluence and dose equivalent at various
locations in the treatment room were calculated and compared to those obtained from a thick iron
target bombarded by parallel proton beams, the simplified geometry on which analytical methods
are based. The neutron spectral fluence distributions were similar for both methods, with deeply
penetrating high-energy neutrons (E > 10 MeV) being most prevalent along the beam central axis,
and low-energy neutrons predominating the neutron spectral fluence in the lateral region.
However, unlike the inverse square falloff used in conventional analytical methods, this study
shows that the neutron dose equivalent per therapeutic dose in the treatment room decreased with
distance approximately following a power law, with an exponent of about −1.63 in the lateral
region and −1.73 in the downstream region. Based on the simulated data according to the detailed
nozzle modeling, we developed an empirical equation to estimate the neutron dose equivalent at
any location and distance in the treatment vault, e.g. for cases in which detailed Monte Carlo
modeling is not feasible. We applied the simulated neutron spectral fluence and dose equivalent to
a shielding calculation as an example.

1. Introduction
Proton beams exhibit a finite range, leading to dose distributions that deliver almost zero
dose distal to the target volume (Wilson 1946). Currently, proton beams that use scattering
systems are employed in most proton therapy units to laterally spread and flatten the beam.
In a typical scattered beam treatment nozzle, protons pass through a rotating range
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modulator wheel to spread the proton dose in depth. The proton beam is conformed laterally
to the target volume using a collimating aperture and in depth with a range compensator
(Koehler et al 1975, 1977, Gottschalk et al 1991). As protons pass through or stop in these
beam-shaping devices, a fraction of them undergo inelastic nuclear interactions that release
high-energy neutrons. These neutrons are the principal concern in shielding a proton therapy
vault due to their abundance and highly penetrating nature (NCRP 2003).
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Analytical methods have been used in designing shielding for many proton therapy facilities,
such as the Northeast Proton Therapy Center (NTPC) (Newhauser et al 2002b), the Proton
Therapy Facility at the National Cancer Center in Korea (Kim et al 2005) and the Roberts
Proton Therapy Center at the University of Pennsylvania facility (Avery et al 2008). The list
is not exhaustive because neutron shielding calculations for many other proton facilities are
not available in the open literature. The analytical methods are typically based on a
simplified treatment unit and shielding vault geometry and rely on approximations to
simplify the modeling of neutron production and transport. One analytical approach
commonly used to calculate neutron attenuation in shielding walls was proposed by Moyer
(1962) and subsequently tested by Tesch (1985) for use in shielding high-energy proton
facilities. Moyer’s model includes terms to take into account neutron production and
attenuation length in the shielding wall; these are typically based on limited experimental or
calculated data obtained using parallel proton beams striking a copper or iron stopping
target. While Moyer’s model provides an acceptable accuracy in some applications, its use
in proton therapy shielding calculations leads to substantial uncertainties (Titt and
Newhauser 2005). There are several sources of uncertainty in the analytical shielding
calculations, including (1) approximations in the modeling of the treatment nozzle and its
enclosure, (2) estimation of the number of protons required for a specified clinical workload,
(3) calculation of the number and energy distribution of neutrons generated per proton, (4)
evaluation of the neutron energy distribution as a function of emission angle, (5) calculation
of the neutron dose equivalent as a function of location in the treatment room and (6)
determination of the attenuation length of the shielding wall (e.g. concrete) as a function of
angle. Cases in which the uncertainty is large have led to a substantial overestimation of the
required neutron shielding (Newhauser et al 2002b, Titt and Newhauser 2005). In most
cases, the analytical methods were conservative, although the degree of over-shielding has
been highly variable. Under-prediction of the required shielding thickness is also possible,
which would potentially pose safety issues or require administrative restrictions on the
allowable clinical caseload of the facility. The large uncertainties notwithstanding, analytical
models remain popular for neutron shielding calculations because of their simplicity and
speed when compared with Monte Carlo simulations. Previous studies by Zheng et al
(2007a, 2007b) suggest that it may be possible to reduce these uncertainties by developing
more realistic models of neutron production rates for proton treatment units that use
scattering systems and apertures to shape the fields.
Neutron production in the nozzle and neutron exposure for patients have been studied with
both Monte Carlo methods and measurements (Agosteo et al 1998, Binns and Hough 1997,
Fontenot et al 2008, Jiang et al 2005, Polf and Newhauser 2005, Polf et al 2005, Schneider
et al 2002, Taddei et al 2008, 2009, Tayama et al 2006, Titt and Newhauser 2005, Wroe et

Phys Med Biol. Author manuscript; available in PMC 2014 August 04.

Zheng et al.

Page 3

NIH-PA Author Manuscript

al 2007, Yan et al 2002, Zheng et al 2007a, 2007b, 2008, Mesoloras et al 2006, Roy and
Sandison 2004, Siebers et al 1992, Newhauser et al 2009). In previous studies (Mesoloras et
al 2006, Zheng et al 2008, Newhauser et al 2002a, Yan et al 2002), it has been shown that
neutron energy spectra vary with the location around the nozzle. Also, some studies have
shown that the neutron dose equivalent as a function of the distance from the isocenter
around the nozzle does not follow the inverse-square law (Polf et al 2005, Zheng et al
2007a, 2007b). How these findings apply to shielding design in other locations and extended
distances, i.e. far from the patient, is unknown. Monte Carlo simulations have been used in
some recent shielding calculations, either together with an analytical method or for
verification purposes. Titt and Newhauser (2005) and Kim et al (2005) used Monte Carlo
methods to verify some previous analytical shielding calculations with a simplified nozzle
geometry, and Avery et al (2008) simulated the neutron spectra for a variety of target
materials bombarded by protons. Detailed studies evaluating the neutron spectra and the
neutron dose equivalent in a proton vault using a realistic nozzle and developing a more
detailed understanding of its effect on shielding design are very few.
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The purpose of this study was to calculate the neutron spectral fluence produced for a
contemporary passive scattering proton treatment unit at various locations in the treatment
vault using detailed Monte Carlo modeling of the nozzle system and to estimate the
corresponding neutron dose equivalent and shielding requirements at various angles relative
to the beam direction. In addition, we developed an analytical model to estimate the neutron
dose equivalent at any location and distance in the treatment vault for cases in which
detailed Monte Carlo modeling is not feasible.

2. Method and materials
2.1. MC nozzle modeling

NIH-PA Author Manuscript

The scattered proton therapy unit we simulated was manufactured by Hitachi America, Ltd
(Brisbane, CA). Proton beams entering the nozzle may have energies of up to 250 MeV. By
selecting different scattering foils according to tumor size, the proton beams may be
scattered laterally to one of three field sizes—small, medium or large, corresponding to
maximum uncollimated field diameters at the isocenter plane of 14.1 cm, 25.5 cm and 35.4
cm (Newhauser and Smith 2003). In this study, we only used proton beams of 250 MeV, the
highest energy provided by this machine, because this energy produces the greatest number
of neutrons (Zheng et al 2008). We selected to study only the medium field size; the most
commonly used of the three field sizes available. We modeled the key components in the
nozzle, including a range modulator wheel, scattering system, range shifter and aperture, as
well as the local shielding in the nozzle. Each device was modeled in great detail so that
approximations in its geometry would produce a negligible impact on simulation results.
The downstream surface of the aperture was located 20 cm upstream of the isocenter.
Modeling and simulations were performed for an unmodulated proton beam. Figure 1 shows
a schematic diagram of the modeled nozzle and the layout of the modeled neutron receptors.
We used the MCNPX Monte Carlo radiation transport code (version 2.6) (Pelowiz 2005) to
simulate the proton therapy beam delivery system. MCNPX is a general-purpose code that
can track most of the particles, including protons and neutrons. Its application in proton
Phys Med Biol. Author manuscript; available in PMC 2014 August 04.
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therapy simulations has been extensively benchmarked against measurements in proton
therapy applications (Fontenot et al 2005, Herault et al 2005, Newhauser et al 2002b, Polf
and Newhauser 2005, Polf et al 2005, Titt and Newhauser 2005, Tayama et al 2006,
Giebeler et al 2009). The standard MCNPX nuclear interaction cross-section libraries
(Chadwick et al 1999) were used for energies up to 150 MeV, and physics models (Bertini
1969, Yariv and Fraenkel 1979) were used to estimate hadronic cross-sections above 150
MeV. Both protons and neutrons were tracked in simulations. The cutoff energy for proton
transport was 1 MeV. The neutron spectral fluence was tallied over each spherical air
neutron receptor that was 12 cm in diameter. An in-house code was used to automatically
generate MCNPX input files that model the proton treatment nozzles. More details on the
nozzle and its modeling can be found in Zheng et al (2007a, 2006) and Newhauser et al
(2008).
2.2. Neutron spectra and neutron dose equivalent

NIH-PA Author Manuscript

We simulated the spectral neutron fluences at various locations of the proton therapy vault,
as shown in figure 1. We divided the room into two regions: (1) the downstream region,
where the neutron receptors were located at angles (θ) 0, 15, 30, 45, 60, 75 and 90° relative
to the beam axis and at selected distances (r) of up to 800 cm from the isocenter and (2) the
lateral region, where neutron receptors were located at selected distances away (x) and along
(z) from the central axis.
The fluence was tallied in 438 logarithmic energy bins for neutrons of energy up to 250
MeV. 5 × 108 or 1 × 109 protons were tracked per simulation to ensure that the statistical
uncertainties for dose equivalent calculations were no more than 5%. Most of the fluence
spectra and neutron ambient dose equivalent calculations were conducted for a nozzle with a
closed aperture and without a phantom present. To verify that a closed aperture was a valid
approximation of the clinical setting, we compared the results to those for separate
simulations of a beam passing through a nozzle with an open aperture and then into a
phantom, with all other parameters identical to those for the closed aperture setting. The
phantom was a 30 × 30 × 30 cm3 water cube with its upstream surface located at the
isocenter level.

NIH-PA Author Manuscript

Neutron spectral fluences were converted to the neutron dose equivalent using an in-house
code and dose conversion factors from International Committee of Radiological Protection
(ICRP) Publication 74 (1996). We used the ambient dose equivalent, H*(10), an operational
quantity, for quantification of the neutron dose equivalent because it provides a conservative
estimate of the equivalent dose, a protection quantity. This quantity is defined as the dose
equivalent that would be produced by the corresponding expanded and aligned field in the
International Commission on Radiation Units and Measurements (ICRU) sphere (30 cm in
diameter) at a depth of 10 mm on the radius opposing the direction of the aligned field
(ICRU 1985, ICRP 1991). For brevity of notation, we will denote H*(10) as H hereafter. H
can be calculated as the product of the neutron spectral fluence, Φ, and the fluence-to-doseequivalent conversion coefficient, H/Φ, which varies with the neutron energy and was taken
from ICRP Publication 74 (1996). By summarizing the products of the neutron spectral
fluence per incident proton, Φ/p and H/Φ over all energy bins, the neutron ambient dose
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equivalent per proton entering the nozzle, H/Φ, at each receptor location was calculated by
using
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(1)

where i and n are the index and the total number of neutron energy bins, respectively, and
(H/Φ)i and Φi/p are the ambient dose equivalent per unit neutron fluence for neutrons and
the neutron fluence per incident proton in the ith energy bin from the simulations,
respectively.
The neutron ambient dose equivalent per therapeutic absorbed dose, H/D, was calculated by
dividing the H/p value by the therapeutic absorbed dose (D/p) value, which was obtained at
the location of the maximum absorbed depth dose in a water phantom along the central axis
in a separate simulation, as previously described (Zheng et al 2007a).
2.3. Analytical fitting of neutron ambient dose equivalent distribution

NIH-PA Author Manuscript

Ideally, a simple analytical equation would be used to estimate neutron exposures at any
location and distance for shielding calculations. Previous studies (Polf et al 2005, Zheng et
al 2007a) have shown that a low-order power law function fits neutron ambient dose
equivalent data quite well for locations downstream of the snout and around the nozzle. In
this study, we tried to use a similar equation for extended distances up to 8 m and at
locations in both the lateral and downstream regions. Since neutrons are produced in each
component along the nozzle’s central axis, in the lateral region around the nozzle, we used a
line source model to approximate the distributed neutron source and estimated the neutron
ambient dose equivalent. At locations in the region downstream of the snout, the neutrons
generated in the aperture and snout predominated the neutron ambient dose equivalent
values. This is because neutrons from upstream components were partially shielded by the
local shielding and/or downstream components, and the majority of neutrons were produced
when a large portion of protons were stopped in the aperture and snout. Therefore, we
modeled the ambient dose equivalent as a function of distance from a point located at the
isocenter. For both the lateral and downstream regions, we used a power law equation to fit
the simulated neutron ambient dose equivalent data:

NIH-PA Author Manuscript

(2)

where d is the distance from the isocenter (r in figure 1) for downstream region locations,
and the distance away from the central axis (x in figure 1) for lateral region locations,
(H/D)d0 is the neutron ambient dose equivalent per therapeutic proton dose at the reference
distance d0 and α is the exponent governing the power law function.
Note that we simulated the H/D values for a completely closed aperture setting with
unmodulated proton beams to make them independent of any patient-specific setting. To
account for the influence of field size and spread-out Bragg peak (SOBP) width, we applied
a field size correction factor, Cf, and an SOBP correction factor, Cm, to the above equation,
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following the methods proposed by Zheng et al (2007a). Therefore, the H/D value at the
distance d for a field size of f and an SOBP width of m, (H/D)d,f,m, was estimated using
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(3)

where f 0 and m0 are the aperture size and the modulation for a reference setup, respectively,
i.e. a closed aperture and an unmodulated beam (pristine peak) in this study.
As identified in previous studies (Mesoloras et al 2006, Zheng et al 2007b, 2008), the
dependence of the neutron dose equivalent on field size is weak, and neutron exposure
typically decreases as field size increases. Also, our previous study (Zheng et al 2008)
showed that the neutron dose equivalent per therapeutic dose almost doubles for an SOBP of
16 cm compared to a pristine peak. To be conservative and simplify the equation, we used
Cf = 1 and Cm = 2 for all field sizes and modulation widths. To further simplify the equation,
we used d0 = 1 m. Therefore, equation (3) became
(4)
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where (H/D)0 is the neutron ambient dose equivalent per therapeutic absorbed dose at 1 m
from the isocenter for a pristine peak with a closed aperture and d is the distance as
previously defined measured in meters.
2.4. Comparison of MC and Moyer’s model
To compare with Moyer’s model, a simplified geometry was simulated. Neutron spectra and
dose equivalent for each receptor were generated for an iron target bombarded by narrow
parallel proton beams, the geometry assumed by Moyer’s model. The iron target was a
cylinder 8 cm in height and 16 cm in diameter, similar to what was used by Tayama et al
(2002). The iron target was located at the isocenter with the cylinder central axis aligned to
the beam axis. The neutron receptors were distributed in the lateral and downstream regions
in the same way as shown in figure 1, except that all nozzle components were removed. The
neutron spectra and dose equivalent from the simplified geometry were compared to those
from simulations using a detailed nozzle modeling.

NIH-PA Author Manuscript

2.5. Shielding calculation
Given a neutron spectral fluence Φ(En) and neutron ambient dose equivalent per therapeutic
dose at any location (H/D)d, the neutron ambient dose equivalent at any distance d with a
shielding wall of thickness t could be calculated by
(5)

where W is the workload and TVL is the equilibrium tenth-value layer of the material used
for shielding. Note that TVL is a function of Φ(En), which varies with the location.
Therefore, the value of TVL needs to be either calculated or simulated using the detailed
neutron spectra shown in figure 2. Replacing Hd,t with the design aim (that is, the
permissible dose equivalent limit) P in equation (5), the wall thickness t can be solved by
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Note that equations (5) and (6) apply to a deep barrier penetration calculation. For thinner
shielding barriers, separate TVL values may be used for the first and equilibrium tenth-value
layers of the shielding material, following the approach given in NCRP Report 151 (2005).
Also, neutrons from possible adjacent treatment rooms and proton transport devices are not
considered here.

3. Results
3.1. Neutron spectral fluence

NIH-PA Author Manuscript

The neutron spectral fluences for the modeled proton therapy nozzle at selected locations are
shown in figure 2. There were two pronounced peaks in the spectrum, a low-energy peak
composed of isotropic neutrons produced by the evaporation processes and a high-energy
peak composed of forward-peaked neutrons from intra-nuclear cascade reactions. For
locations in the downstream region (figure 2(a)), the amplitude of the low-energy peak
relative to the high-energy peak increased significantly with increasing angle relative to the
central axis, but did not change much with distance from the isocenter. In the lateral region
(figure 2(b)) and at locations close to the central axis (i.e. x = 1 m), the neutron spectra were
similar in shape, but the high-energy peak decreased when moving from downstream (z = 1
m) to more upstream locations (z = 3 m). At a distance far away from the central axis (i.e. x
= 4 m), the neutron spectra at along-axis locations in the lateral region were almost identical.
3.2. Neutron ambient dose equivalent

NIH-PA Author Manuscript

Table 1 shows the calculated neutron ambient dose equivalent values at selected locations in
the treatment room based on Monte Carlo-simulated neutron spectral fluence. The neutron
ambient dose equivalent fell off sharply with the distance away from the nozzle.
Interestingly, when the distance to the nozzle (r) was constant in the downstream, we found
that H/D values did not change much with angle. Similarly, for the constant off-axis distance
(x) in the lateral region, the H/D value did not change with distance along the central axis
(z). Because of differences in the shape of the neutron spectral fluence, shielding
requirements at various locations could differ even when the neutron ambient dose
equivalent rates in the room were similar. For example, at θ = 0° in the downstream region,
the high-energy neutrons predominated; therefore, more shielding would be required than at
other angles because high-energy neutrons have a greater TVL than low-energy neutrons.
The simulated neutron ambient dose equivalent values at all locations are plotted in figure 3,
interpolated to facilitate visualization.
3.3. Analytic fitting of neutron ambient dose equivalent distribution
The low-order power-law expression in equation (2) was used to fit MC data at all angles in
the downstream region and all along axis distances in the lateral region, respectively. The
neutron ambient dose equivalent at any location in the treatment room generated by a 25.5
cm diameter, 250 MeV proton beam without range modulation (i.e. a pristine peak) could be
estimated by
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in the downstream region, or by
(8)

NIH-PA Author Manuscript

in the lateral region, where r and x are the distances (in m) from the isocenter or the central
axis as previously defined (figure 1). Therefore, the H/D value was about 1.44 mSv Gy−1 at
1 m in the downstream region and 1.19 mSv Gy−1 in the lateral region. As indicated in
equations (7) and (8), the H/D value decreased with distance, approximately following a
power law with an exponent of −1.73 in the downstream region and −1.63 in the lateral
region. As shown in figure 4, the analytical function fits the simulated data well, typically
within 10% and with a maximum deviation of 27%. This level of agreement is quite good
considering the simplicity of the analytical model and the large uncertainties in high-energy
neutron dosimetry measurements and calculations. When we take the effect of field size and
SOBP width into account in the shielding calculation, e.g. by applying the field size and
modulation factors described earlier, a factor of 2 can be multiplied on the right-hand side of
equations (7) and (8).
3.4. Comparison with water phantom simulations
We simulated neutron fluence spectra and ambient dose equivalents using an open aperture
and a cubic water phantom and compared the results with those simulated in air with a
closed aperture. Because a water phantom in the downstream region should have minimal
effects on neutron exposure in the lateral region, we only examined effects on locations in
the downstream region. As shown in figure 5, the neutron spectral fluences were quite
similar to those obtained with a closed aperture (figure 2(a)); in both cases, two energy
peaks occurred and the relative contributions of the high-energy peak and low-energy peak
varied with an angle relative to the beam central axis. The main difference existed for the
neutron fluence spectra immediately downstream of the water phantom (i.e. r = 1 m and θ =
0°); the amplitude of the low-energy peak was much lower than the corresponding neutron
spectral fluence obtained in air with a closed aperture. This result is likely due to the water
phantom preferentially absorbing the low-energy neutrons generated in the upstream nozzle.
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The ratio of open to closed field neutron ambient dose equivalent values is shown in table 2.
At locations immediately downstream of the water phantom, i.e. when θ is 0°, this ratio was
nearly 0.5. The dose was reduced mainly because (1) water generates fewer neutrons than
brass (ICRU 2000) and (2) the water tank serves as an effective shielding device against
those neutrons generated in the nozzle. At locations away from the central axis in the
downstream region, the neutron ambient dose equivalent is almost the same in the two cases.
Therefore, our closed-aperture simulations are a good approximation of a more realistic
phantom setting in most locations and are conservative in locations downstream of the water
phantom, within a factor of about 2.
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3.5. Comparison of MC and Moyer’s model
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The simulated neutron fluence spectra around a thick iron target bombarded by a parallel
proton beam is shown in figure 6 for selected locations. In the downstream region, the
neutron fluence spectra almost overlapped for r = 1 m and r = 4 m for a common angle θ.
This was expected because a point source approximation is valid for the simplified
geometry. The shapes of the neutron spectra based on a thick iron target were quite similar
to those based on the detailed nozzle modeling (figure 2(a)), except that the high-energy
peak for θ = 45° was slightly greater in magnitude. In the lateral region, unlike the neutron
spectra in figure 2(b), the iron-target neutron spectra (figure 6(b)) had almost the same
shapes at all locations and the high-energy peaks were less pronounced.
We also calculated the H/D values based on the simplified geometry and compared them to
the results based on a detailed nozzle modeling. As shown in table 3, the H/D values based
on a thick iron target were much greater in the beam direction in the downstream region
(e.g. about 2.5 times higher for r = 4 m and θ = 0°), but less in the lateral region (e.g. about
40% lower when x = 4 m).

NIH-PA Author Manuscript

3.6. Shielding calculations
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Using the methods described above, one may calculate the required shielding barrier of
thickness t to attenuate the neutron ambient dose equivalent rate to a safe level using
equation (6). An example was shown here for a situation in which we seek to calculate the
required thickness of the shielding wall between the proton beam nozzle and the control
room. The following assumptions were applied: the workload (W) was 20 000 Gy/year; the
control room was in the lateral region of the proton beam nozzle and 6 m away from the
central axis of the proton beam; and the material for the wall shielding was normal concrete
with a density of 2.34 g cm−3. By simulating neutron attenuation through a concrete wall
with an initial neutron spectral fluence taken from figure 2, we found that the attenuation
length (TVL) for normal concrete was 78 cm. Also, based on the simulated data (table 2 or
figure 3) or the analytical fitting equation, the neutron ambient dose equivalent (H/D) at 6 m
was found to be 0.06 mSv Gy−1 for an unmodulated proton beam of 250 MeV and about
0.12 mSv Gy−1 for a modulated beam (assuming an SOBP factor of 2). The recommended
design aim (P) for a controlled area, e.g. the control room, was 5 mSv/year according to
NCRP Report 151 (NCRP 2005). According to equation (6), the thickness of the shielding
wall should be

(9)

It should be noted that the value of the workload used in this example may not be
representative of a specific proton therapy clinic. Accurate determinations of W values are
expected to vary strongly with the design and implementation of the proton therapy clinic
(Newhauser et al 2002b).
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We studied the neutron spectral fluence and neutron ambient dose equivalent at selected
locations in a proton therapy room and examined how these data could be used in
calculations of the required shielding barrier thickness. In the downstream region, the shape
of the neutron spectral fluence changed rapidly with angle relative to the beam direction but
changed little with the distance from the isocenter. High-energy neutron fluences, the main
concern in shielding, were greatest along the beam central axis. In the lateral region, the
shape of the neutron spectral fluence was found to be similar at all locations. In both the
downstream and lateral regions, the neutron ambient dose equivalent per therapeutic
absorbed dose in the treatment room decreased sharply with increasing distance,
approximately following a power law. An empirical equation was developed to estimate the
neutron ambient dose equivalent at an arbitrary location and distance in the treatment vault.
An example was given to illustrate a method to use the simulated neutron spectral fluence
and ambient dose equivalent results in a practical shielding calculation. The neutron fluence
spectra and dose equivalent from a realistic nozzle were compared to those from a thick iron
target bombarded by a parallel proton beam. While the shapes of neutron fluence spectra
were similar in both cases, the thick iron target method significantly overestimated the
neutron dose equivalent in the beam forward directions and underestimated in the lateral
region.
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The simulated neutron spectral fluence obtained here is consistent with those reported in
previous studies (Yan et al 2002, Zheng et al 2008, Avery et al 2008). The results showed
that the neutron ambient dose equivalent did not change much with angle relative to the
central beam axis in the downstream region. This result is consistent with those in studies by
Yan et al (2002) and Polf et al (2005); however, some analytical methods use a large factor
to scale the 90° value to estimate the 0° value (e.g. a factor of 20 was used for the NPTC
shielding design). The main reason for the much larger neutron dose at the 0° angle in the
previous analytical method is that a thick copper or iron target with a parallel narrow proton
beam was used, while in reality a broad proton beam interacts with the whole nozzle, which
contains components all along the beam line composed of various materials. Also, this study
shows that the neutron ambient dose equivalent decreases with distance following a power
law, with an exponent of about −1.73 in the downstream region and −1.63 in the lateral
region, which is consistent with previous studies by Polf et al (2005) and Zheng et al
(2007a). However, conventional analytical methods typically assume an ideal point source
and use an inverse square law to calculate the change of the neutron ambient dose equivalent
as a function of distance. Since neutrons are generated in several components in the nozzle
and in the patient, modeling H/D with a single point source and pure inverse square falloff is
a first-order approximation. While it is possible to use multiple neutron point sources from
some of the major components in the nozzle for better estimation, such modeling is
relatively complicated because it needs to estimate neutron productions from each individual
component, where protons may lose only part of their energy. Also, such modeling cannot
take into consideration local shielding effects by other components of the nozzle. A simple
analytical fit was derived based on simulations from a detailed nozzle model, which fit the
simulated H/D values at various locations in the treatment room within an accuracy of 27%.
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The better accuracy was obtained by empirically estimating the value of the exponent,
thereby approximately taking into account the distributed nature of the neutron sources.
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Most of the neutron fluence spectra and ambient dose equivalent data presented here were
based on simulations of a nozzle with a closed aperture and without a phantom present,
which is different from a typical patient treatment, for which an open aperture is used.
However, the results were compared with those from simulations of nozzles with an open
aperture and a water phantom, with no significant difference except in the downstream
region when angles relative to the central beam are small, where the neutron ambient dose
equivalent with a closed aperture was typically conservative and within a factor of 2 of the
phantom calculations. Furthermore, the closed-aperture method allows an estimation of the
neutron dose exposures independent of patient-specific settings and devices such as range
compensators and apertures, which differ from field to field. Also, only unmodulated proton
beams were simulated in this study. When the SOBP width increases, more protons will
interact with the range modulation wheel; therefore, more neutrons will be produced from
the range modulation wheel. This change may increase the neutron exposure at locations
close to the range modulation wheel in the lateral region. However, because the thinner steps
of the range modulation wheel contribute most to the SOBP, the effect is expected to be
relatively small.
In addition, no measurements were made specifically for this study to confirm the Monte
Carlo estimates. However, the nozzle model has been validated with a wide range of
measurements (Titt et al 2008), and simulations of the neutron dose equivalent have been
verified by measurements carried out by other groups (Moyers et al 2008, Tayama et al
2006, Wroe et al 2007). Finally, it is noteworthy that the analytical model developed here
reproduced H/D values specific to the Hitachi proton facility. We will be applying these
techniques to other proton units to determine the accuracy of generalizing the model.
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With many additional proton therapy facilities being planned and built, there is an urgent
need for improved shielding calculation methods and data for application in future shielding
designs. Preferably, Monte Carlo modeling and simulation should be used in shielding
design when the detailed nozzle design is available. Compared to conventional analytical
methods, which are based on a simplified geometry and rely on numerous assumptions,
Monte Carlo methods can simulate the detailed proton source and nozzle geometry and
therefore provide a more accurate neutron dose equivalent prediction. Also, the simulated
neutron spectral fluence at selected locations can be used for accurate determination of
attenuation length in shielding materials. Furthermore, we presented a relatively accurate
analytical method to estimate the neutron ambient dose equivalent in shielding calculations
in situations where detailed Monte Carlo modeling is not feasible.
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Figure 1.
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Monte Carlo model of a scattered treatment nozzle. The proton beams enter the nozzle from
the left through a vacuum window (A), a beam profile monitor (B), a range-modulator wheel
(C), a second scatterer (D), a range shifter assembly (E), backup and primary beam monitors
(F), shielding plates (G), a snout (H), and a final collimator or aperture (I). The location of
the isocenter is indicated by J. The open circles outside the nozzle represent neutron
receptors (K). The position of the neutron receptor is determined by the distance from the
isocenter (r) and the angle relative to the central axis (θ) in the downstream region, and the
coordinates (x, z) in lateral regions, with the isocenter being the origin. The figure is not to
scale.
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Figure 2.

Neutron spectral fluence Φ(En) at selected angles θ and the distance to the isocenter r in the
downstream region (a), and at selected distances away (x) and along (z) the central axis in
the lateral region (b). Simulations were performed for a passively scattered proton beam of
25.5 cm diameter and 250 MeV proton energy at the nozzle entrance with a fully closed
final collimator (aperture).
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Figure 3.

Neutron ambient dose equivalent per therapeutic absorbed dose (H/D) as a function of
distance along the beam axis (z) and away from the beam axis (x). Interpolation was
performed to facilitate visualization.
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Figure 4.

Neutron ambient dose equivalent per therapeutic absorbed dose (H/D) as a function of the
distance to the isocenter, r, in the downstream region (a), and as a function of distance from
the central axis for locations, x, in the lateral region (b). The dose falloff with distance
approximately follows a power law, with an exponent of −1.73 in the downstream region
and −1.63 in the lateral region. R is the correlation coefficient.
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Figure 5.

Neutron spectral fluence (Φ(En)) at selected angles (θ) and distances from the isocenter (r)
in the downstream region. Simulations were performed with a 25.5 cm diameter, 250 MeV
proton beam with an open 10 × 10 cm2 aperture irradiating a 30 × 30 × 30 cm3 water
phantom.
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Figure 6.

Neutron spectral fluence Φ(En) at various angles (θ) and distances to the isocenter (r) in the
downstream region (a), and at various distances away (x) and along (z) the central axis in the
lateral region (b). Simulations were performed for a thick iron target bombarded by a narrow
proton beam of 250 MeV.
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Table 1
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Neutron ambient dose equivalent per delivered dose, H/D in mSv Gy−1, for a 25.5 cm diameter, 250 MeV
proton beam at some of the evaluated locations with a closed aperture. r, θ, x and z are defined in figure 1.
Lateral region
z

x

1m

Downstream region

θ

r

1m

2m

3m

1.28

1.43

1.35

0°

45°

90°

1m

1.03

1.05

1.31

2m

0.49

0.48

0.39

2m

0.36

0.39

0.47

3m

0.24

0.25

0.18

3m

0.19

0.20

0.24

4m

0.15

0.15

0.10

4m

0.12

0.13

0.15

6m

0.06

0.06

0.06

6m

0.06

0.07

0.08
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Table 2
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Ratio of H/D values determined with an open aperture of 10 × 10 cm2 and a water phantom present (H/Dwater)
to those determined with a closed aperture and without a phantom present (H/Dair) for a 25.5 cm diameter, 250
MeV proto beam. r is the distance from the isocenter and θ is the angle with respect to the proton beam central
axis as shown in figure 1.
H/Dwater/H/Dair

θ

r
0°

45°

90°

1m

0.52

0.68

0.90

2m

0.50

0.76

0.95

3m

0.50

0.78

0.96

4m

0.51

0.80

0.96
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Table 3
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Ratio of H/D values determined with an iron target bombarded by a parallel 250 MeV proton beam to those
determined with a closed aperture and a detailed nozzle modeling for a 25.5 cm diameter, 250 MeV proton
beam. r, θ, x, and z are defined in figure 1.
Lateral region
z

x

1m

Downstream region

θ

r

1m

2m

3m

0°

45°

90°

0.69

0.26

0.14

1m

4.8

3.0

1.2

2m

0.67

0.47

0.36

2m

3.3

2.0

0.81

3m

0.66

0.51

0.55

3m

2.8

1.7

0.72

4m

0.64

0.54

0.66

4m

2.5

1.5

0.64
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